SS Innovations International, Inc. Shares Key Update
SS Innovations International, Inc. (OTC: SSII) has recently shared important updates regarding its audit process and the trading status of its common stock. The company, recognized for its pioneering surgical robotic technologies, strives to make advanced robotics available for surgical procedures worldwide.
Transition in Accounting Firm
In response to recent developments, the company informed shareholders about a significant change in their accounting practices. The Securities and Exchange Commission (SEC) has barred BF Borgers CPA PC from serving as an independent registered public accounting firm, which has implications for SS Innovations and several other companies. Consequently, the company decided to end its relationship with Borgers and appointed BDO India as its new accounting firm.
Reaudit and Internal Review Process
Following this transition, SS Innovations instructed BDO to conduct a re-audit of its financial statements for the years ending December 31, 2023, and December 31, 2022. At the same time, the company has launched an internal review of its accounting policies and internal control systems.
On August 14, 2024, the company submitted a Form 8-K to the SEC, announcing plans to restate its audited financial statements for the specified years, as well as interim unaudited financials for multiple quarters. This filing includes detailed information regarding these changes.
Current Market Trading Status
Due to missed filing deadlines, the trading status of SS Innovations' common stock has been affected. The company’s stock was downgraded from the OTC Pink Tier to the Expert Market Tier by OTC Markets, Inc. The Expert Market serves as a restricted platform for companies that are not current with their filings, which limits public access and liquidity for SS Innovations' shares.
It is important to note that the company is diligently working to complete the audit and restore timely filings to regain its status on the OTC Pink Tier. By achieving compliance, SS Innovations aims to eventually pursue an uplisting to a more prominent trading venue.
Effect on Operations and Leadership Enhancements
The challenges related to the previous accounting firm have not negatively impacted the operational capabilities or growth prospects of SS Innovations, as detailed in their ongoing SEC reports and public communications. Additionally, the leadership team has been bolstered by the recent appointment of two independent directors—Dr. Frederic H. Moll and Timothy P. Adams—each bringing decades of expertise in surgical robotics and healthcare management.
About SS Innovations International, Inc.
SS Innovations is dedicated to the development of surgical robotic technologies. The company's flagship offerings include the state-of-the-art “SSi Mantra” surgical robotic system and a comprehensive array of surgical instruments known as “SSi Mudra.” These innovations facilitate a wide range of surgical procedures while ensuring affordability and accessibility for healthcare providers around the globe.
Headquartered in India, SS Innovations is gearing up to expand its advanced robotic surgical solutions on a global scale. This growth strategy not only focuses on delivering cutting-edge technology but also on actively seeking regulatory approvals in the United States and the European Union, with plans for market entry in the coming years.
Regulatory Approvals and Clinical Validation
The SSi Mantra system has already obtained regulatory approval for medical devices in India, demonstrating its clinical applications across more than 70 surgical procedures. The company is committed to advancing its technology with the aim of achieving FDA and CE Mark approvals in the near future, targeting clinical adoption in various healthcare settings.
Frequently Asked Questions
What recent changes occurred with SS Innovations' accounting firm?
SS Innovations transitioned from BF Borgers CPA PC to BDO India as their new independent registered public accounting firm following SEC sanctions against Borgers.
How does the Expert Market status affect SS Innovations' stock?
Being on the Expert Market restricts public access and limits trading liquidity, which could influence perceptions of stock valuation.
What steps is SS Innovations taking to regain its former trading status?
The company is actively working to finalize its audit and submit the necessary amended reports to the SEC to return to the OTC Pink Tier.
What new additions were made to SS Innovations' leadership team?
Two independent directors, Dr. Frederic H. Moll and Timothy P. Adams, have recently joined the board, bringing extensive experience in surgical robotics and healthcare management.
What innovative products does SS Innovations offer?
SS Innovations has developed the SSi Mantra surgical robotic system and a variety of surgical instruments, aiming to enhance surgical outcomes while making advanced technology accessible to healthcare providers.
